June 30-July 3, 2013
Highlights From IAS 2013: 6 HIV-Related Studies With Major Clinical Importance
Stem-Cell Transplant Recipients, Now Off Antiretrovirals, Still Appear Virus-Free
Very Early HIV Treatment Leads to Another New Case of a Functional Cure
WHO Embraces More Aggressive Stance to Starting HIV Treatment
More IAS 2013 Headlines:
The 7th International Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) is a major scientific meeting that takes place once every two years. An estimated 5,000 delegates -- including many of the world's most esteemed HIV researchers, clinicians and policy experts -- are expected to attend this year's conference in Kuala Lumpur. While there, they will discuss hundreds of presented abstracts and examine the clinical relevance and policy implications of the latest developments in the field.
TheBodyPRO.com's coverage of IAS 2013 will ultimately feature a wide array of study summaries, expert analyses and video interviews. We are proud to partner with the International Association of Providers of AIDS Care and IFARA to bring you highlights from this critical scientific meeting.
|Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.|